Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab., Bakall, Benjamin, Folk James C., H Boldt Culver, Sohn Elliott H., Stone Edwin M., Russell Stephen R., and Mahajan Vinit B. , Am J Ophthalmol, 2013 Jul, Volume 156, Issue 1, p.15-22.e1, (2013)

Thrombin receptor signaling to cytoskeleton requires Hsp90., Pai, K S., Mahajan V B., Lau A, and Cunningham D D. , J Biol Chem, 2001 Aug 31, Volume 276, Issue 35, p.32642-7, (2001)